For example, the neutrophil percentage to albumin ratio (NPAR) has been proposed as a dual-purpose biomarker for breast cancer risk and prognosis, aiding in early detection and personalized treatment planning (Su et al., 2025). This evidence concerns the gene ALB and breast carcinoma.